MDAATMidlothian Drug and Alcohol Action Team (UK)
References in periodicals archive ?
Thus, in this study, we aimed to demonstrate the utilization of serum IL-18 level as a biomarker for disease activity and organ damage in patients with DM or PM using the MDAAT.
All MDAAT evaluations were performed by a group of experienced and qualified physicians in the Department of Rheumatology and Immunology of the West China Hospital within one week of patient enrollment.
10) Furthermore, we found that serum IL-18 level was positively correlated with disease activity in patients with DM, based on the MDAAT assessment which includes the MYOACT global disease activity score and MITAX disease activity total score.